RAC 3.33% $1.55 race oncology ltd

Ann: Race In-person Investor Briefing Invitation Perth, page-48

  1. 2,777 Posts.
    lightbulb Created with Sketch. 3414
    IMO @Davisite is spinning the wrong narrative (disgruntled ex-directors).

    It's really just been disgruntled shareholders (a minority). We should be leaning into this. The RC220 program opportunity was so enormous that it couldn't be denied. The de-prioritisation (shelving) of RC110 frustrated retail holders with shorter investment horizons.

    The positive, RC220 is now about to hit the clinic. RAC is back where it was 2-3 years ago but with a far greater TAM. The market hasn't cottoned on to this fact.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.